Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma

NCT03628209 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma
Osteosarcoma in Children
Osteosarcoma Recurrent
Sarcoma

Interventions

DRUG: Nivolumab
DRUG: Azacitidine
PROCEDURE: Post Treatment Surgery

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]